Tema Neuroscience and Mental Health ETF

MNTL

Valor de mercado US$ 10,5 mi

NEW YORK--(BUSINESS WIRE)--After careful consideration, Tema ETFs LLC, investment adviser to Tema Luxury ETF and the Tema Neuroscience and Mental Health ETF (the "Funds"), has recommended, and the Board of Trustees of Tema ETF Trust has approved, the termination and liquidation of the Funds. Accordingly, the Funds are expected to cease operations and liquidate on or about August 1, 2025 (the "Liquidation Date").

Tech investing poses one of the more important, and more fascinating, questions before investors entering 2025. Tech firms contributed outsized returns for the whole market, but do they pose concentration risks?

Tema ETFs recently launched the neuroscience and mental health ETF. MNTL ETF is designed to invest in companies at the forefront of combating neurological diseases and psychiatric disorders.

Although 14 new ETFs debuted in the U.S. this past week, closure announcements came in even stronger, largely due to Global X pruning its lineup. Launches during the week included funds from BondBloxx, WisdomTree, Innovator, JPMorgan, and Range ETFs.